Caplin Point Laboratories Ltd (BOM:524742)
₹ 2009.45 -0.9 (-0.04%) Market Cap: 152.74 Bil Enterprise Value: 144.03 Bil PE Ratio: 31.01 PB Ratio: 6.01 GF Score: 98/100

Q4 2024 Caplin Point Laboratories Ltd Earnings Call Transcript

May 16, 2024 / 10:30AM GMT
Release Date Price: ₹1366.2 (+1.04%)
Operator

Ladies and gentlemen, good day, and welcome to Caplin Point Laboratories Q4 FY '24 earnings conference call.

(Operator Instructions)

Please note that this conference is being recorded. I now hand the conference over to Mr. Tushar Manudhane from Motilal Oswal. Thank you, and over to you, sir.

Tushar Manudhane;Partheeban Vivek Siddarth
Motilal Oswal Securities Limited;Caplin Point Laboratories Ltd - Chief Operating

Thanks, Manuja. Good evening, everyone. On behalf of Motilal Oswal Financial Services, we welcome you all to the Q4 FY '24 Conference Call of Caplin Point Laboratories Limited. I take this opportunity to welcome the management of Caplin Point Labs represented by Mr. C.C. Paarthipan, Chairman of the company; Mr. Vivek Partheeban, COO of the company. And we also have with us Dr. Sridhar Ganesan, Managing Director; Mr. D. Muralidharan, CFO; and Mr. Sathya Narayanan, Deputy CFO.

I would now like to hand the conference over to Caplin Point management for the opening remarks. Over to you, sir.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot